Avacta Group (AVCTF) News Today $0.65 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Avacta Group: Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in BarcelonaOctober 24, 2024 | finanznachrichten.deAvacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® PlatformOctober 17, 2024 | finance.yahoo.comAvacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific OfficerOctober 15, 2024 | uk.finance.yahoo.comAvacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR SymposiumOctober 10, 2024 | markets.businessinsider.comAvacta Group Plc (RTQ1.F)September 19, 2024 | nz.finance.yahoo.comAvacta Group: Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) CongressSeptember 8, 2024 | finanznachrichten.deAvacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) CongressSeptember 8, 2024 | markets.businessinsider.comIs Avacta the best ex-penny stock to buy today?September 7, 2024 | msn.comAvacta Group Plc's (LON:AVCT) largest shareholders are retail investors with 58% ownership, institutions own 41%July 23, 2024 | finance.yahoo.comDown 63% in 2024, what’s going on with the Avacta (AVCT) share price?May 18, 2024 | msn.comAvacta Group - AVA6000 Abstract Release by AACR and Full Presentation UpdateApril 5, 2024 | finance.yahoo.comAvacta Group PLC AVCTFApril 4, 2024 | morningstar.comAvacta Group PLC AVCTNovember 11, 2023 | morningstar.comAvacta Group's (LON:AVCT) growing losses don't faze investors as the stock soars 11% this past weekNovember 8, 2023 | finance.yahoo.comAvacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsOctober 5, 2023 | finance.yahoo.comAvacta Group Plc (LON:AVCT) is largely controlled by institutional shareholders who own 53% of the companySeptember 7, 2023 | finance.yahoo.comAvacta sees shares rise on new equity payment for South Korea ventureJune 5, 2023 | lse.co.ukAvacta Group's (LON:AVCT) investors will be pleased with their solid 218% return over the last five yearsJune 1, 2023 | finance.yahoo.comAvacta Group Plc's (LON:AVCT) Business Is Trailing The Industry But Its Shares Aren'tMay 5, 2023 | finance.yahoo.comAvacta Group's Shares Rise on US Site Openings for Cancer Study Patient EnrolmentApril 7, 2023 | marketwatch.comAvacta doses first patient in fifth cohort of AVA6000 phase 1 studyApril 6, 2023 | lse.co.ukAvacta opens first two clinical investigator sites in US for AVA6000April 6, 2023 | lse.co.ukAvacta Announces First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation StudyApril 5, 2023 | finance.yahoo.comAvacta to Present Pre-Clinical Data on AVA3996 at the American Association for Cancer Research Annual MeetingApril 1, 2023 | finance.yahoo.comAvacta Group plc: Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics DivisionMarch 31, 2023 | finanznachrichten.deAvacta Group Plc (LON:AVCT) is favoured by institutional owners who hold 55% of the companyMarch 31, 2023 | finance.yahoo.comAvacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical StudyJanuary 17, 2023 | benzinga.comInvestors in Avacta Group (LON:AVCT) have made a incredible return of 538% over the past three yearsDecember 1, 2022 | finance.yahoo.comAvacta GroupSeptember 11, 2022 | fool.co.ukAvacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug AdministrationSeptember 5, 2022 | finance.yahoo.comAvacta Announces Phase I Clinical Study of AVA6000 to Advance to the Fourth CohortSeptember 1, 2022 | finance.yahoo.comEven though Avacta Group (LON:AVCT) has lost UK£39m market cap in last 7 days, shareholders are still up 304% over 3 yearsMay 3, 2022 | finance.yahoo.comAvacta Announces AffyXell Joint Venture Milestone and Increased Equity StakeApril 13, 2022 | finance.yahoo.comWhat You Need To Know About Avacta Group Plc's (LON:AVCT) Investor CompositionJanuary 18, 2022 | finance.yahoo.comAvacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000November 29, 2021 | finance.yahoo.comAvacta Group (LON:AVCT) shareholder returns have been enviable, earning 486% in 3 yearsNovember 19, 2021 | finance.yahoo.com Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover AVCTF Media Mentions By Week AVCTF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVCTF News Sentiment▼0.000.56▲Average Medical News Sentiment AVCTF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVCTF Articles This Week▼00▲AVCTF Articles Average Week Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ASPHF News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AVCTF) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
